相似文献
1
[From gene defect to drug therapy for obesity?].
Dtsch Med Wochenschr. 2003 May 9;128(19):1034.
2
[Genetic abnormalities of regulatory mechanism of appetite].
Nihon Rinsho. 2001 Mar;59(3):449-55.
3
The neuronal histamine H(1) and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure.
Peptides. 2006 Feb;27(2):326-32. doi: 10.1016/j.peptides.2005.02.028. Epub 2005 Dec 15.
4
[The central melanocortin system and its role in energy homeostasis].
Ann Endocrinol (Paris). 1999 Mar;60(1):3-9.
5
New targets for obesity pharmacotherapy.
Clin Pharmacol Ther. 2007 May;81(5):748-52. doi: 10.1038/sj.clpt.6100163.
6
To eat or not to eat - how the gut talks to the brain.
N Engl J Med. 2003 Sep 4;349(10):926-8. doi: 10.1056/NEJMp038114.
7
Defective melanocortin 4 receptors in hyperphagia and morbid obesity.
N Engl J Med. 2003 Mar 20;348(12):1160-3. doi: 10.1056/NEJMe030013.
8
Hypothalamic peptides as drug targets for obesity.
Curr Opin Pharmacol. 2001 Dec;1(6):651-5. doi: 10.1016/s1471-4892(01)00110-2.
9
Yellow mice, red hair, and childhood obesity: the melanocortinergic pathway in energy homeostasis.
J Pediatr. 2001 Aug;139(2):177-81. doi: 10.1067/mpd.2001.117574.
10
Obesity therapy: altering the energy intake-and-expenditure balance sheet.
Nat Rev Drug Discov. 2002 Apr;1(4):276-86. doi: 10.1038/nrd770.
Zotero 插件